Table 9 Measures (indicators) for primary and secondary outcome of interest
Factors to be measured | Indicator |
|---|---|
Primary outcome of interest | |
 Improved and continuous availability of generic drugs at PHC | Percentage of PHC where all generic medicines for NCD patients adequately available in last three months |
 Increased and regular access to quality medicines for patients with NCD | Percentage of NCD patients/patient groups visit intervention PHC in last three months |
 Out-of-pocket expenses among patients with NCD | Percentage reduction in median OOP expenditure on medicines per year among NCD patients. |
 The marginal cost of the intervention to that of the outcome | Incremental cost effective ratio |
 Improved compliance to standard treatment guidelines by the PHC | Percentage MOs followed prescription practices as per the standard treatment guidelines. |
 Improved demand of generic drugs among the patients | Percentage increase in patients availing generic drugs from the PHC compared to what it was at three months back |
 Improved utilization of medicines among NCD patients | Percentage of NCD patients/ patient groups obtained complete and regular medication for last three months. |
Secondary outcome of interest | |
 Better coordination among health staffs with regards to NCD patient group formation | - Percentage increase in number of patient groups formed. - Percentage increase in number of new diabetes patients registered in last three months for a given PHC. - Percentage increase in number of new hypertension patients registered in last three months for a given PHC. |
 Better drug procurement | Percentage PHCs where drug procurement is up to date for the last quarter. |
 Conduction of NCD clinics | Percentage PHCs conduct NCD days in last three months |
 Better reporting and recording by the pharmacists at PHC | Percentage PHCs where medicines were dispensed as prescribed |